Patent · US Active

Aminoquinazoline and pyridopyrimidine derivatives

US9592235B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2016
Grant dateMar 14, 2017
Priority date
Expiry dateJun 16, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of treating cancer in a patient by administering a compound of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.